Arcus Biosciences, Inc. (RCUS)
29.21
-1.38
(-4.51%)
USD |
NYSE |
Aug 28, 16:00
29.18
-0.03
(-0.10%)
After-Hours: 20:00
Arcus Biosciences EPS Diluted (TTM) : -3.904 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.904 |
| March 31, 2026 | -3.183 |
| December 31, 2025 | -3.300 |
| September 30, 2025 | -3.431 |
| June 30, 2025 | -3.170 |
| March 31, 2025 | -4.191 |
| December 31, 2024 | -3.099 |
| September 30, 2024 | -3.154 |
| June 30, 2024 | -3.099 |
| March 31, 2024 | -3.103 |
| December 31, 2023 | -4.152 |
| September 30, 2023 | -4.001 |
| June 30, 2023 | -3.948 |
| March 31, 2023 | -3.852 |
| December 31, 2022 | -3.711 |
| September 30, 2022 | 0.9258 |
| June 30, 2022 | 0.7123 |
| March 31, 2022 | 0.5509 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.4237 |
| September 30, 2021 | -4.100 |
| June 30, 2021 | -2.960 |
| March 31, 2021 | -2.799 |
| December 31, 2020 | -2.343 |
| September 30, 2020 | -1.904 |
| June 30, 2020 | -2.440 |
| March 31, 2020 | -2.154 |
| December 31, 2019 | -1.933 |
| September 30, 2019 | -1.841 |
| June 30, 2019 | -1.585 |
| March 31, 2019 | -1.263 |
| December 31, 2018 | -2.222 |
| September 30, 2018 | -2.240 |
| June 30, 2018 | -13.85 |
| March 31, 2018 | -13.53 |
| December 31, 2017 | -12.16 |
| September 30, 2017 | -11.86 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 3.347 |
| AVITA Medical, Inc. | -1.444 |
| Iovance Biotherapeutics, Inc. | -0.7214 |
| Editas Medicine, Inc. | -0.7446 |
| Recursion Pharmaceuticals, Inc. | -1.036 |